Skip to content

Clinical trials

Phase 2/3 Leukemia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia Phase: Phase 2/3 Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20042
20062
20102
20111
20141
20164
20172
20181
20191
20201
20221
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status8
Recruiting7
Active, not recruiting2
Terminated2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Monash University5
Nanfang Hospital, Southern Medical University3
St. Jude Children's Research Hospital2
Actinium Pharmaceuticals1
Amgen1
Ann & Robert H Lurie Children's Hospital of Chicago1
Chimeric Therapies1
Cristália Produtos Químicos Farmacêuticos Ltda.1
European Organisation for Research and Treatment of Cancer - EORTC1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia30
Precursor Cell Lymphoblastic Leukemia-Lymphoma12
Lymphoma11
Leukemia, Myeloid, Acute9
Neoplasms8
Myelodysplastic Syndromes7
Anemia, Refractory, with Excess of Blasts5
Infections5
Neoplasms, Plasma Cell5
Congenital Abnormalities4

Trials

Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.